AXIM BIOTECHNOLOGIES, INC. Litigation Settlement, Expense
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Litigation Settlement, Expense of $955.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementExpense · last filed 2024-08-19
- AXIM BIOTECHNOLOGIES, INC. litigation settlement, expense for the quarter ending 2024-06-30 was $0.00.
- AXIM BIOTECHNOLOGIES, INC. litigation settlement, expense for the quarter ending 2024-03-31 was $955.00K.
- AXIM BIOTECHNOLOGIES, INC. litigation settlement, expense for fiscal 2023 was $955.00K.
- AXIM BIOTECHNOLOGIES, INC. litigation settlement, expense for fiscal 2022 was $0.00.
| Period end | Litigation Settlement, Expense 3 month | Litigation Settlement, Expense 6 month | Litigation Settlement, Expense 12 month |
|---|---|---|---|
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-08-19 | $955.00K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $955.00K 10-Q/A · filed 2024-05-22 | ||
| 2023-12-31 | $955.00K 10-K · filed 2024-04-16 | ||
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 |